R 80122

Known as: Acetamide, N-cyclohexyl-N-methyl-2-(((phenyl(1,2,3,5-tetrahydro-2-oxoimidazo(2,1-b)quinazolin-7-yl)methylene)amino)oxy)-, (E)-, R-80122, R80122 
 

Topic mentions per year

Topic mentions per year

1992-1999
02419921999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
At present, phosphodiesterase III inhibitors are commonly used for the treatment of low cardiac output states. Despite their… (More)
Is this relevant?
1994
1994
The selective phosphodiesterase III (PDE-III) inhibitor R80122 ((E)-N-cyclohexal-N-methyl-2-[[[phenyl-(1,2,3,5- tetrahydro-2… (More)
Is this relevant?
1994
1994
The present study was designed to compare the effects of enoximone and R 80122, a highly selective phosphodiesterase (PDE) III… (More)
Is this relevant?
1994
1994
R 80122 is a new short-acting phosphodiesterase type III inhibitor. In a preliminary investigation, three patients, scheduled for… (More)
Is this relevant?
1994
1994
R80122 (0.3 mg/kg body weight), a new phosphodiesterase inhibitor, was tested in ten patients undergoing coronary artery bypass… (More)
Is this relevant?
1992
1992
R 79595 (N-cyclohexyl-N-methyl-2-[[[phenyl (1,2,3,5-tetrahydro-2 oxoimidazo [2,1-b]-quinazolin-7-yl) methylene] amin] oxy… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1992
1992
The cardiac and hemodynamic effects of R80122, a new specific phosphodiesterase III inhibitor, were studied in a closed-chest… (More)
Is this relevant?
1992
1992
The cardiac in vitro effects of R 80122, a novel phosphodiesterase (PDE) inhibitor, were investigated and compared with those of… (More)
Is this relevant?
1992
1992
Phosphodiesterase III inhibitors have been established in recent years in the therapy of congestive heart failure. Many… (More)
Is this relevant?
1992
1992
R 80122 is a newly synthesized, selective phosphodiesterase III inhibitor. The cardiac and hemodynamic effects of this compound… (More)
Is this relevant?